Evidence map›Paper›PMID 29470322›Full record

GuidelineJournal of pediatric gastroenterology and nutrition2018

Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Rachel Rosen, Yvan Vandenplas, Maartje Singendonk, Michael Cabana, Carlo DiLorenzo, Frederic Gottrand, Sandeep Gupta, Miranda Langendam, Annamaria Staiano, Nikhil Thapar and 2 more

Registry-linked trialOpen access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Journal of pediatric gastroenterology and nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03014453 (Gastroesophageal Reflux Poses a Potential Risk for Late Complications of BPD), which is not on this map. Cited by 311 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
311citing papers in PubMed, 11 pooled it
78.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03014453 completednot on this map

Gastroesophageal Reflux Poses a Potential Risk for Late Complications of BPD: A Prospective Study

TypeobservationalSponsorShengjing HospitalRan2017 to 2018Enrolled187ConditionsGastroesophageal Reflux, Bronchopulmonary Dysplasia
3 · Its place in the literature

Who cites it

311 citing papers in PubMed, 11 syntheses or guidelines pooled it, 1,507 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Pooled it
  6. Guideline
  7. Pooled it
  8. Guideline
  9. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2023
    Guideline
  10. Pharmacological treatment of gastro-oesophageal reflux in children.The Cochrane database of systematic reviews · 2023
    Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Review
  18. Article
  19. Observational
  20. Article

251 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 6 countries.

Rachel Rosen *Center for Motility and Functional Gastrointestinal Disorders, Division of Gastroenterology, Children's Hospital Boston, Boston, MA.
Yvan Vandenplas *KidZ Health Castle, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgium.
Maartje SingendonkEmma Children's Hospital/AMC, Amsterdam, The Netherlands.
Michael CabanaDivision of General Pediatrics, University of California, San Francisco, CA.
Carlo DiLorenzoDivision of Pediatric Gastroenterology, Nationwide Children's Hospital, The Ohio State University, Columbus, OH.
Frederic GottrandCHU Lille, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Lille, France.
Sandeep GuptaDivision of Pediatric Gastroenterology, Hepatology and Nutrition, University of Illinois, Peoria, IL.
Miranda LangendamDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands.
Annamaria StaianoDepartment of Translational Medical Science, Section of Pediatrics, University of Naples ‘‘Federico II,’’ Naples, Italy,
Nikhil ThaparGreat Ormond Street Hospital for Children, London, UK
Neelesh TipnisDepartment of Pediatrics, University of Mississippi Medical Center, Jackson, MS.
Merit TabbersEmma Children's Hospital/AMC, Amsterdam, The Netherlands.
Emma Kinderziekenhuis · NLAcademic Medical Center · NLBoston Children's Hospital · USJackson Memorial Hospital · USLille’s Cardiology Hospital · FRNationwide Children's Hospital · USPeoria campus of the University of Illinois System · USUniversity of California, San Francisco · USUniversity of Naples Federico II · ITVrije Universiteit Brussel · BE

Funding

The impact of upper gastrointestinal dysmotility on aspiration-associated aerodigestive disorders in childrenR01DK097112 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Rachel L Rosen · 2015 to 2026
$4.9M
NIDDK NIH HHS R01 DK097112Wellcome Trust
6 · The paper itself

Abstract

This document serves as an update of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) 2009 clinical guidelines for the diagnosis and management of gastroesophageal reflux disease (GERD) in infants and children and is intended to be applied in daily practice and as a basis for clinical trials. Eight clinical questions addressing diagnostic, therapeutic and prognostic topics were formulated. A systematic literature search was performed from October 1, 2008 (if the question was addressed by 2009 guidelines) or from inception to June 1, 2015 using Embase, MEDLINE, the Cochrane Database of Systematic Reviews and the Cochrane Central Register of Controlled Clinical Trials. The approach of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) was applied to define and prioritize outcomes. For therapeutic questions, the quality of evidence was also assessed using GRADE. Grading the quality of evidence for other questions was performed according to the Quality Assessment of Studies of Diagnostic Accuracy (QUADAS) and Quality in Prognostic Studies (QUIPS) tools. During a 3-day consensus meeting, all recommendations were discussed and finalized. In cases where no randomized controlled trials (RCT; therapeutic questions) or diagnostic accuracy studies were available to support the recommendations, expert opinion was used. The group members voted on each recommendation, using the nominal voting technique. With this approach, recommendations regarding evaluation and management of infants and children with GERD to standardize and improve quality of care were formulated. Additionally, 2 algorithms were developed, 1 for infants <12 months of age and the other for older infants and children.

Indexed as

AdolescentAntacidsBiomarkersChildChild, PreschoolCombined Modality TherapyComplementary TherapiesDiagnosis, DifferentialEndoscopy, GastrointestinalEsophageal pH MonitoringFundoplicationGastroesophageal RefluxHumansInfantInfant, NewbornManometryAntacidsBiomarkersProton Pump Inhibitors

Identifiers

PMID29470322
PMCPMC5958910
OpenAlexW2182760264

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.